Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Cold Stored Platelets
United Therapeutics Europe Ltd
Acute Blood Loss
1 trial -
D-cycloserine
United Therapeutics Europe Ltd
Autistic Disorder
1 trial -
DCS (D-Cycloserine ) + Prolonged Imaginal Exposure
United Therapeutics Europe Ltd
Post Traumatic Stress Disorder
1 trial -
Dexamethasone
United Therapeutics Europe Ltd
Shoulder Pain
1 trial -
Dinutuximab
United Therapeutics Europe Ltd
Small Cell Lung Cancer
1 trial -
Direct-Acting Oral Anticoagulants (used as per local standard practice)
United Therapeutics Europe Ltd
Traumatic Intracranial Haemorrhage
1 trial -
Distress Thermometer and Problems List
United Therapeutics Europe Ltd
Cancer
1 trial -
Dose
United Therapeutics Europe Ltd
Chronic Migraine, Headache
1 trial -
Doxycycline
United Therapeutics Europe Ltd
Lymphedema
3 trials -
Doxycycline (200mg/day) or Placebo
United Therapeutics Europe Ltd
Persian Gulf Syndrome
1 trial -
Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment
United Therapeutics Europe Ltd
COVID19
1 trial -
Educational Dementia training
United Therapeutics Europe Ltd
Dementia
1 trial -
Educational Intervention
United Therapeutics Europe Ltd
Hematologic Malignancies
1 trial -
Eicosapentaenoic Acid and Docosahexaenoic Acid (EPA + DHA)
United Therapeutics Europe Ltd
Cardiovascular Disease
1 trial -
Empagliflozin 10 mg
United Therapeutics Europe Ltd
Acute Myocardial Infarction
1 trial -
Endoscopic submucosal dissection
United Therapeutics Europe Ltd
Colorectal Neoplasms
1 trial -
Enhanced standard management
United Therapeutics Europe Ltd
Pacemaker Complication
1 trial -
Erenumab
United Therapeutics Europe Ltd
Fibromyalgia
1 trial -
Eribulin Mesylate
United Therapeutics Europe Ltd
Breast Adenocarcinoma
1 trial -
Everolimus
United Therapeutics Europe Ltd
Pediatric Heart Transplantation
1 trial -
Exoskeletal assisted walking
United Therapeutics Europe Ltd
Spinal Cord Injuries
1 trial -
Expressive Writing
United Therapeutics Europe Ltd
Posttraumatic Stress Disorder
1 trial -
Extensively Hydrolyzed formula
United Therapeutics Europe Ltd
Cow Milk Allergy
1 trial -
Farletuzumab
United Therapeutics Europe Ltd
Ovarian Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources